BPC-157 and the FDA

2 articles in this topic.

Complete Guides

BPC-157 and the FDA: Category 2 Explained

The FDA moved BPC-157 to Category 2 in 2023, blocking compounding pharmacies. Here is what the classification means, why it happened, and what changed in 2026.

18 min read|Mar 20, 2026

All Articles

BPC-157 and the FDA

Which 14 Peptides Are Moving Back to Category 1?

The FDA reclassification returns 14 of 19 peptides to Category 1 status. Here is every peptide on the list, which 5 stay restricted, and what changes.

15 min read|Mar 21, 2026